Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study
Rheumatology and Therapy · 2024-06 · 11 (3) · 501-521
DOI: 10.1007/s40744-024-00650-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 02.03.2024. Verfasst von Beatriz Frade-Sosa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España, Openbanak.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain.
- Department of Immunology-CDB, Hospital Clinic of Barcelona, Barcelona, Barcelona, Spain.
- Unit of Synthesis and Biomedical Applications of Peptides, Institute for Advanced Chemistry of Catalonia. Consejo Superior de Investigaciones Científicas (IQAC-CSIC), Barcelona, Spain.
- Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, Barcelona, Spain.
- Department of Rheumatology, Hospital Clinic of Barcelona, Barcelona, IDIBAPS, Carrer Villarroel 170, 08170, Barcelona, Spain. sanmarti@clinic.cat.
Förderung
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
- Openbanak
Zitieren
APA
Frade-Sosa, B., Ponce, A., Ruiz-Ortiz, E., De Moner, N., Gómara, M. J., Azuaga, A. B., Sarmiento-Monroy, J. C., Morlà, R., Ruiz-Esquide, V., Macías, L., Sapena, N., Tobalina, L., Ramirez, J., Cañete, J. D., Yague, J., Auge, J. M., Gomez-Puerta, J. A., Viñas, O., Haro, I., & Sanmarti, R. (2024). Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and Therapy, 11(3), 501-521. https://doi.org/10.1007/s40744-024-00650-9
Vancouver
Frade-Sosa B, Ponce A, Ruiz-Ortiz E, De Moner N, Gómara MJ, Azuaga AB, et al. Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and Therapy. 2024;11(3):501-521. doi:10.1007/s40744-024-00650-9
BibTeX
@article{FradeSosa2024,
author = {Frade-Sosa, Beatriz and Ponce, Andrés and Ruiz-Ortiz, Estíbaliz and De Moner, Noemí and Gómara, María J and Azuaga, Ana Belén and Sarmiento-Monroy, Juan C and Morlà, Rosa and Ruiz-Esquide, Virginia and Macías, Laura and Sapena, Nuria and Tobalina, Lola and Ramirez, Julio and Cañete, Juan D and Yague, Jordi and Auge, Josep M and Gomez-Puerta, José A and Viñas, Odette and Haro, Isabel and Sanmarti, Raimon},
title = {Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study},
journal = {Rheumatology and Therapy},
year = {2024},
volume = {11},
number = {3},
pages = {501--521},
doi = {10.1007/s40744-024-00650-9}
}
EUVIMED